| Document and Entity Information | Mar. 10, 2020 |
| Cover [Abstract] | |
| Entity Registrant Name | Invitae Corp |
| Security Exchange Name | NYSE |
| Amendment Flag | true |
| Entity Central Index Key | 0001501134 |
| Document Type | 8-K/A |
| Document Period End Date | Mar. 10, 2020 |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-36847 |
| Entity Tax Identification Number | 27-1701898 |
| Entity Address, Address Line One | 1400 16th Street |
| Entity Address, City or Town | San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94103 |
| City Area Code | (415) |
| Local Phone Number | 374-7782 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.0001 par value per share |
| Trading Symbol | NVTA |
| Entity Emerging Growth Company | false |
| Amendment Description | On March 10, 2020, Invitae Corporation (“Invitae”), filed a Current Report on Form 8-K (the “Original Form 8-K”) with the Securities and Exchange Commission to report certain transactions, including its transaction with respect to Orbicule BV, a Belgian limited liability company operating under the name “Diploid” (“Diploid”).This Amendment No. 1 to Current Report on Form 8-K/A amends the Original Form 8-K to include Item 2.01, which was inadvertently excluded from the Original Form 8-K. |
